It is vital for biotech companies to run the right clinical trial and not cut costs with trial design or patient recruitment, ...

This could give enterprises access to a 3D, AI-accelerated future without requiring investment in costly GPU-scale ...

PI's new objective focusing stage excels in fast nano-focusing applications, such as DNA sequencing, laser-technology, wafer metrology, super-resolution microscopy, medical technology, and slide ...

Apar Industries Ltd, Symphony Ltd, Concord Biotech Ltd and Intellect Design Arena Ltd are among the other gainers in the BSE's 'A' group today, 08 May 2025.

Bio-Techne surpasses profit expectations with significant growth in its research products, leading to the announcement of a ...

Cadence supplies software that firms such as Apple use to design chips. But over the past several years, it has expanded to ...

Discover how a flexible protein can rearrange itself to multitask efficiently, revolutionizing medicine, agriculture, and ...

“Today’s announcement reflects the growing challenges facing businesses delivering major infrastructure across the UK. But it ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

A Beachwood-based biotechnology company has secured $20 million in financing that will enable an expansion in personnel, ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...